February 13, 2025 - 02:27

The Senate Finance Committee approved President Donald Trump’s choice to be America’s top trade negotiator on Wednesday, largely along party lines. Jamieson Greer, who has been nominated for the position, is expected to play a crucial role in shaping U.S. trade policy during a time of significant global economic challenges.
The committee's vote reflects the ongoing partisan divide in Congress, with most Republicans supporting Greer's nomination while Democrats expressed concerns about his previous positions and the potential impact on American workers. Greer is known for his experience in international trade and has previously worked in various capacities within the U.S. Trade Representative's office.
As the new trade negotiator, Greer will be tasked with navigating complex trade relationships and addressing issues such as tariffs and trade agreements that have become increasingly contentious. His appointment may also influence ongoing negotiations with key trading partners and could have lasting implications for the U.S. economy.
June 8, 2026 - 22:27
What history tells us about Marvell's upcoming S&P 500 inclusionMarvell Technology shares have been climbing sharply after the announcement that the company will join the S&P 500 index on June 22. Investors are betting that the move will bring fresh demand from...
June 8, 2026 - 04:51
Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...
June 7, 2026 - 03:13
Apple Stock: Buy, Sell, or Hold?Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...
June 6, 2026 - 22:38
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are MissingEli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...